Alam Kamran
SEC CIK 1793412 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | CFO | 1.44M | — | $1.40M | 14 | 2021-08-18 | 2026-02-04 |
Most active insiders at TSHA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nagendran Sukumar | Pres, Head of R, D, Dir | — | $5.33M |
| 2 | Nolan Sean P. | CEO, Dir | — | $840.2K |
| 3 | Alam Kamran | CFO | — | $492.5K |
| 4 | Long Alison S | Dir | — | — |
| 5 | Sepp-Lorenzino Laura | Dir | — | — |
| 6 | Stalfort John A III | Dir | — | — |
| 7 | Donenberg Phillip B. | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-04 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $4.52 | -1,655 | 1.44M | -0.1% | -$7,481 | |
| M | 2026-01-27 | 2026-01-23+ | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $4.72 | -102.8K | 1.44M | -7% | -$485.0K |
| D | 2026-01-14 | 2026-01-12 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | A - Grant | $0.00 | +359.0K | 1.55M | +30% | $0 |
| 2025-08-22 | 2025-08-21 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $2.85 | -54.5K | 1.19M | -4% | -$155.3K | |
| 2025-03-13 | 2025-03-11 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | F - Tax | $1.69 | -29.8K | 1.24M | -2% | -$50.4K | |
| D | 2025-01-03 | 2025-01-02 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | A - Grant | $0.00 | +431.0K | 1.27M | +51% | $0 |
| 2024-02-06 | 2024-02-02 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | F - Tax | $1.51 | -1,288 | 840.9K | -0.2% | -$1,945 | |
| D | 2024-01-04 | 2024-01-02 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | A - Grant | $0.00 | +590.4K | 842.2K | +234% | $0 |
| 2023-08-25 | 2023-08-24 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $2.33 | -33.0K | 258.0K | -11% | -$76.9K | |
| 2023-06-02 | 2023-05-31 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | A - Grant | — | +6,230 | 291.0K | +2% | — | |
| D | 2023-02-06 | 2023-02-02 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | A - Grant | — | +18.7K | 284.8K | +7% | — |
| 2022-08-24 | 2022-08-23 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $3.47 | -3,325 | 266.1K | -1% | -$11.5K | |
| M | 2022-08-22 | 2022-08-18+ | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $3.70 | -28.7K | 269.4K | -10% | -$106.0K |
| M | 2021-08-20 | 2021-08-18+ | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $16.88 | -33.0K | 310.0K | -10% | -$557.0K |
Purchase Sale Sale after option exercise All abbreviations